in a news release, the drug's manufacturer, amgen, said the list price will be 5 a month or ,900 annually. costs to patients may vary depending on insurance.
. taking ustekinumab�a biologic that targets a different aspect of the immune system," gelfand said.
http://lm360.us/Kepley-son-of-Tocchio-from-Kherson?Maynezbro=252